Resource use and costs of treating acute cough/lower respiratory tract infections in 13 European countries: results and challenges (Q47398172)

15 January 2018

title

Resource use and costs of treating acute cough/lower respiratory tract infections in 13 European countries: results and challenges (English)

1 reference

15 January 2018

author

Joanna Coast

2

1 reference

15 January 2018

Christopher C. Butler

6

1 reference

15 January 2018

author name string

Raymond Oppong

1

1 reference

15 January 2018

Kerry Hood

3

1 reference

15 January 2018

Jacqui Nuttall

4

1 reference

15 January 2018

Richard D Smith

5

1 reference

15 January 2018

GRACE-01 Study Team

7

1 reference

15 January 2018

publication date

3 April 2010

1 reference

15 January 2018

The European Journal of Health Economics

published in

1 reference

15 January 2018

volume

12

1 reference

15 January 2018

issue

4

1 reference

15 January 2018

page(s)

319-329

1 reference

15 January 2018

https://scigraph.springernature.com/pub.10.1007/s10198-010-0239-1

exact match

0 references

cites work

Antibiotic therapy of community respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0239-1

Economic impact of community-acquired and nosocomial lower respiratory tract infections in young children in Germany.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0239-1

Community-acquired lower respiratory tract infections: etiology and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0239-1

Prognostic factors for serious morbidity and mortality from community-acquired lower respiratory tract infections among the elderly in primary care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0239-1

Improving management of patients with acute cough by C-reactive protein point of care testing and communication training (IMPAC3T): study protocol of a cluster randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0239-1

Can antibiotic prescriptions in respiratory tract infections be improved? A cluster-randomized educational intervention in general practice--the Prescription Peer Academic Detailing (Rx-PAD) Study [NCT00272155]

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0239-1

National campaigns to improve antibiotic use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0239-1

What is the role of quality circles in strategies to optimise antibiotic prescribing? A pragmatic cluster-randomised controlled trial in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0239-1

Effect of antimicrobial use and other risk factors on antimicrobial resistance in pneumococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0239-1

Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0239-1

Design, analysis and presentation of multinational economic studies: the need for guidance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0239-1

Resource costing for multinational neurologic clinical trials: methods and results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0239-1

Collecting unit cost data in multicentre studies. Creating comparable methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0239-1

Analysis of costs and cost-effectiveness in multinational trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0239-1

Variation in antibiotic prescribing and its impact on recovery in patients with acute cough in primary care: prospective study in 13 countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0239-1

Delayed prescribing of antibiotics for upper respiratory tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0239-1

Outpatient antibiotic use in Europe and association with resistance: a cross-national database study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0239-1

Lower respiratory tract infections: impact on the workplace.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0239-1

Assessing the appropriateness of combining economic data from multinational clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0239-1

Conducting economic evaluations alongside multinational clinical trials: toward a research consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0239-1

The hospital costs of care for stroke in nine European countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0239-1

Primary care diabetes in Hungary

21 January 2018

1 reference

12 December 2020

Herbal medicine in Europe--relaxing regulatory standards

1 reference

12 December 2020

Centre-specific or average unit costs in multi-centre studies? Some theory and simulation

1 reference

12 December 2020

Assessing generalisability by location in trial-based cost-effectiveness analysis: the use of multilevel models

1 reference

12 December 2020

Community-acquired pneumonia: the annual cost to the National Health Service in the UK.

1 reference

12 December 2020

Type of contract and supplier-induced demand for primary physicians in Norway

1 reference

12 December 2020

Treatment of community-acquired lower respiratory tract infections in adults

1 reference

12 December 2020

Optimizing antibiotic prescribing for acute cough in general practice: a cluster-randomized controlled trial

1 reference

12 December 2020

10.1007/S10198-010-0239-1

Identifiers

DOI

1 reference

15 January 2018

PubMed ID

20364288

1 reference

15 January 2018